233 related articles for article (PubMed ID: 31366819)
1. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study.
Tokuda H; Sakai F; Yamada H; Johkoh T; Imamura A; Dohi M; Hirakata M; Yamada T; Kamatani N; Kikuchi Y; Sugii S; Takeuchi T; Tateda K; Goto H
Intern Med; 2008; 47(10):915-23. PubMed ID: 18480575
[TBL] [Abstract][Full Text] [Related]
3. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study.
Ohmura SI; Homma Y; Masui T; Miyamoto T
Intern Med; 2022 Apr; 61(7):997-1006. PubMed ID: 34511571
[TBL] [Abstract][Full Text] [Related]
5. Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.
Shimada K; Yokosuka K; Nunokawa T; Sugii S
Clin Rheumatol; 2018 Aug; 37(8):2269-2274. PubMed ID: 29876690
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapy.
Salaffi F; Carotti M; Cervini C
Clin Rheumatol; 1995 Jul; 14(4):458-63. PubMed ID: 7586985
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate.
Crilly A; McInness IB; McDonald AG; Watson J; Capell HA; Madhok R
J Rheumatol; 1995 Feb; 22(2):224-6. PubMed ID: 7738942
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy.
Mori S; Cho I; Ichiyasu H; Sugimoto M
Mod Rheumatol; 2008; 18(3):240-6. PubMed ID: 18306977
[TBL] [Abstract][Full Text] [Related]
9. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.
Polisson RP; Dooley MA; Dawson DV; Pisetsky DS
Arthritis Rheum; 1994 Jan; 37(1):50-6. PubMed ID: 8129764
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
Watanabe K; Sakai R; Koike R; Sakai F; Sugiyama H; Tanaka M; Komano Y; Akiyama Y; Mimura T; Kaneko M; Tokuda H; Iso T; Motegi M; Ikeda K; Nakajima H; Taki H; Kubota T; Kodama H; Sugii S; Kuroiwa T; Nawata Y; Shiozawa K; Ogata A; Sawada S; Matsukawa Y; Okazaki T; Mukai M; Iwahashi M; Saito K; Tanaka Y; Nanki T; Miyasaka N; Harigai M
Mod Rheumatol; 2013 Nov; 23(6):1085-93. PubMed ID: 23212592
[TBL] [Abstract][Full Text] [Related]
13. Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis.
Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
Rev Rhum Engl Ed; 1997 Feb; 64(2):89-94. PubMed ID: 9085442
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and risk factors for mortality in Pneumocystis pneumonia patients with rheumatoid arthritis: A multicentre retrospective cohort study.
Mori S; Ueki Y; Miyamura T; Ishii K; Hidaka T; Yoshitama T; Nakamura K; Suenaga Y
Mod Rheumatol; 2023 Jul; 33(4):723-731. PubMed ID: 35920411
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.
Kuuliala A; Leirisalo-Repo M; Möttönen T; Hannonen P; Nissilä M; Kautiainen H; Korpela M; Julkunen H; Hakola M; Repo H;
Clin Exp Rheumatol; 2005; 23(2):243-6. PubMed ID: 15895898
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis.
Suenaga Y; Yasuda M; Yamamoto M; Nonaka S; Wada T; Shiokawa S; Nobunaga M
Clin Rheumatol; 1998; 17(4):311-7. PubMed ID: 9776115
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature.
Kaneko Y; Suwa A; Ikeda Y; Hirakata M
Mod Rheumatol; 2006; 16(1):36-8. PubMed ID: 16622722
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptor: elevated levels in serum and synovial fluid of patients with rheumatoid arthritis.
Carpenter AB; Eisenbeis CH; Carrabis S; Brown MC; Ip SH
J Clin Lab Anal; 1990; 4(2):130-4. PubMed ID: 2313471
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases.
Yoshida Y; Takahashi Y; Minemura N; Ueda Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2012 Aug; 22(4):509-14. PubMed ID: 21971942
[TBL] [Abstract][Full Text] [Related]
20. [Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab].
Ikeuchi H; Umemoto A; Tsukida M; Sakurai N; Maeshima A; Kuroiwa T; Hiromura K; Nojima Y
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):420-5. PubMed ID: 22041430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
